**CDC data through late August 2026 show 2,903 confirmed U.S. measles cases year-to-date, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991.** Roughly 94% of cases link to outbreaks, with 93–94% occurring among unvaccinated or unknown-status individuals; children and teens aged 5–19 account for about 47% of infections, and hospitalization rates stand near 7%. Declining kindergarten MMR coverage (now ~92.4%) and pockets of low uptake have sustained transmission chains that began in 2025, with recent acceleration reported in Pennsylvania and Ohio. Weekly CDC surveillance updates and the November PAHO review of U.S. elimination status represent key near-term data points that could influence trader assessments of whether final 2026 totals remain elevated or moderate.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоСлучаи кори в США в 2026 году?
Случаи кори в США в 2026 году?
$7,867,874 Объем
$7,867,874 Объем
31 дек. 2026 г.
↑4,5 тыс.
65%
↑3к
99%
↑3,5 тыс.
96%
↑4k
90%
↑5к
50%
↑7,5 тыс.
14%
↑10k
7%
↑12,5 тыс.
7%
$7,867,874 Объем
$7,867,874 Объем
31 дек. 2026 г.
↑4,5 тыс.
$771 Объем
65%
↑3к
$91,467 Объем
99%
↑3,5 тыс.
$14,715 Объем
96%
↑4k
$238,210 Объем
90%
↑5к
$237,281 Объем
50%
↑7,5 тыс.
$187,120 Объем
14%
↑10k
$6,519,347 Объем
7%
↑12,5 тыс.
$353,197 Объем
7%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**CDC data through late August 2026 show 2,903 confirmed U.S. measles cases year-to-date, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991.** Roughly 94% of cases link to outbreaks, with 93–94% occurring among unvaccinated or unknown-status individuals; children and teens aged 5–19 account for about 47% of infections, and hospitalization rates stand near 7%. Declining kindergarten MMR coverage (now ~92.4%) and pockets of low uptake have sustained transmission chains that began in 2025, with recent acceleration reported in Pennsylvania and Ohio. Weekly CDC surveillance updates and the November PAHO review of U.S. elimination status represent key near-term data points that could influence trader assessments of whether final 2026 totals remain elevated or moderate.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Открытие рынка: Feb 16, 2026, 11:51 AM ET
Объем
$7,867,874Дата окончания
1 янв. 2027 г.Открытие рынка
Feb 16, 2026, 11:51 AM ETКто определяет исход
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**CDC data through late August 2026 show 2,903 confirmed U.S. measles cases year-to-date, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991.** Roughly 94% of cases link to outbreaks, with 93–94% occurring among unvaccinated or unknown-status individuals; children and teens aged 5–19 account for about 47% of infections, and hospitalization rates stand near 7%. Declining kindergarten MMR coverage (now ~92.4%) and pockets of low uptake have sustained transmission chains that began in 2025, with recent acceleration reported in Pennsylvania and Ohio. Weekly CDC surveillance updates and the November PAHO review of U.S. elimination status represent key near-term data points that could influence trader assessments of whether final 2026 totals remain elevated or moderate.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Объем
$7,867,874Дата окончания
1 янв. 2027 г.Открытие рынка
Feb 16, 2026, 11:51 AM ETКто определяет исход
0x65070BE91...**CDC data through late August 2026 show 2,903 confirmed U.S. measles cases year-to-date, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991.** Roughly 94% of cases link to outbreaks, with 93–94% occurring among unvaccinated or unknown-status individuals; children and teens aged 5–19 account for about 47% of infections, and hospitalization rates stand near 7%. Declining kindergarten MMR coverage (now ~92.4%) and pockets of low uptake have sustained transmission chains that began in 2025, with recent acceleration reported in Pennsylvania and Ohio. Weekly CDC surveillance updates and the November PAHO review of U.S. elimination status represent key near-term data points that could influence trader assessments of whether final 2026 totals remain elevated or moderate.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы